ACLY alternative splicing correlates with cancer phenotypes is a research paper published in Journal of Biological Chemistry (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA262055
National Institutes of Health
Grant: T32GM133398
National Institutes of Health
Grant: K00CA212455
National Institutes of Health
Grant: F31CA260781
National Institutes of Health
Grant: T32DK007314
NCI NIH HHS
Grant: R01 CA051497
NCI NIH HHS
Grant: P30 CA010815
NCI NIH HHS
Grant: R01 CA057341
National Institutes of Health
Grant: 3T32DK007314-36S1
Diabetes, Endocrine and Metabolic Disease
National Institutes of Health
Grant: 5F31CA260781-02
Molecular and cancer-related roles of ACLY exon 14
National Institutes of Health
Grant: 5R01CA262055-03
Metabolic regulation and inhibition of ATP-citrate lyase
National Institutes of Health
Grant: 4K00CA212455-03
Leveraging polyamine metabolic stress as a novel therapy for prostate cancer
National Institutes of Health
Grant: 2T32GM133398-06
Predoctoral Training at the Chemistry-Biology Interface
FWCI
0.48
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals